FDA Inspection 1253723 — Lifeshare Blood Center
The FDA completed an inspection of Lifeshare Blood Center on Oct 30, 2024 in Texarkana, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 30, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Texarkana, TX (United States)